Fig. 58 (abstract O47).
From: International Society for Therapeutic Ultrasound Conference 2016
A preliminary cellular analysis of treated tumours excised 48 hours post MRgFUS treatment and analyzed with flow cytometry. CD3+, CD4+, and CD8+ are cellular markers for T-cells that are involved in the in vivo immune response. A substantial difference in immune cell infiltration can be observed between the treatment groups